The association of Apo E gene polymorphism; which has a regulatory role in lipid metabolism [29], with both the risk of developing AD and type 2 diabetes mellitus (T2DM) supports this line of research [6, 30]. The gene discussed is APOE; the disease is Alzheimer disease.